The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

Simple item page
dc.contributor.authorDucreux, Miçhel P.
dc.contributor.authorAbou-Alfa, Ghassan Khaled
dc.contributor.authorBekaii-Saab, Tanios S.
dc.contributor.authorBerlin, Jordan
dc.contributor.authorCervantes, Andrés M.R.
dc.contributor.authorDe Baère, Thierry D.
dc.contributor.authorEng, Cathy
dc.contributor.authorGalle, Peter Robert
dc.contributor.authorGill, Sharlene
dc.contributor.authorGruenberger, Thomas
dc.contributor.authorHaustermans, Karin M.G.
dc.contributor.authorLamarca, Angela
dc.contributor.authorLaurent-Puig, Pierre F.
dc.contributor.authorLlovet, Josep M.
dc.contributor.authorLordick, Florian
dc.contributor.authorMacarulla, Teresa Mercade
dc.contributor.authorMukherji, Deborah M.
dc.contributor.authorMuro, Kei
dc.contributor.authorObermannová, Radka Lordick
dc.contributor.authorO'Connor, J. M.
dc.contributor.authorO'Reilly, Eileen Mary
dc.contributor.authorÖsterlund, Pia J.
dc.contributor.authorPhilip, Philip Agop
dc.contributor.authorPrager, G. W.
dc.contributor.authorRuiz-Garcia, Erika Betzabé
dc.contributor.authorSangro, Bruno
dc.contributor.authorSeufferlein, Thomas Theodor Werner
dc.contributor.authorTabernero Romo, JoséM Matías
dc.contributor.authorVerslype, Chris
dc.contributor.authorWasan, Harpreet Singh
dc.contributor.authorvan Cutsem, Éric J.D.G.
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:45:13Z
dc.date.available2025-01-24T11:45:13Z
dc.date.issued2023
dc.description.abstractThis article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options. © 2023 The Author(s)
dc.identifier.doihttps://doi.org/10.1016/j.esmoop.2023.101567
dc.identifier.eid2-s2.0-85160563203
dc.identifier.pmid37263081
dc.identifier.urihttp://hdl.handle.net/10938/30540
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofESMO Open
dc.sourceScopus
dc.subjectChemoembolisation
dc.subjectHepatocellular carcinoma
dc.subjectImmunotherapy
dc.subjectLiver transplantation
dc.subjectRadioembolisation
dc.subjectCarcinoma, hepatocellular
dc.subjectExpert testimony
dc.subjectGastrointestinal neoplasms
dc.subjectHumans
dc.subjectLiver neoplasms
dc.subjectAntineoplastic agent
dc.subjectAblation therapy
dc.subjectCancer diagnosis
dc.subjectCancer patient
dc.subjectCancer radiotherapy
dc.subjectCancer screening
dc.subjectCancer staging
dc.subjectCancer surgery
dc.subjectCancer therapy
dc.subjectChemoembolization
dc.subjectConsensus development
dc.subjectHepatectomy
dc.subjectHuman
dc.subjectInterdisciplinary research
dc.subjectLiver cell carcinoma
dc.subjectLiver cirrhosis
dc.subjectPublication
dc.subjectRadioembolization
dc.subjectReview
dc.subjectSpain
dc.subjectSystemic therapy
dc.subjectTerminal cancer
dc.subjectExpert witness
dc.subjectGastrointestinal tumor
dc.subjectLiver tumor
dc.titleThe management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2023-5442.pdf
Size:
442.13 KB
Format:
Adobe Portable Document Format
Download

Collections

Internal Medicine